Literature DB >> 32473533

Polarization and function of tumor-associated macrophages mediate graphene oxide-induced photothermal cancer therapy.

Xiangyu Deng1, Hang Liang1, Wenbo Yang1, Zengwu Shao2.   

Abstract

Polarization status of tumor-associated macrophages (TAMs) plays an essential role in tumor growth and invasion. However, emerging treatment like photothermal therapy (PTT), photodynamic therapy (PDT) paid little attention on TAMs. In recent years, photothermal therapy (PTT) has gained immense attention in the anti-tumor strategy field while the effect of PTT on macrophage polarization in a tumor microenvironment has rarely been reported. Here, we used graphene oxide (GO) combined with polyethylene glycol (PEG) as the photothermal material to induce heating effect in macrophages to define its anti-tumor effect in vitro and in vivo. Firstly, we treated the macrophage cell line RAW264.7 with near infrared (NIR) light irradiation and detected their polarization status by flow cytometric and mRNA expression analysis. Following this, we analyzed the migration and invasion ability of an osteosarcoma HOS cell line cultured in a conditioned medium (CM) that contains cytokine generated by macrophages with or without NIR treatment. Finally, we investigated the in vivo effects of NIR-induced macrophage polarization on osteosarcoma growth and invasion. GO-PEG (GP) showed great photothermal effect, thermal stability, and biocompatibility in vitro and in vivo. Photothermal materials can alleviate interleukin-4-induced M2 polarization of macrophages and modulate their anti-tumor capability. Thus, the migration and invasion capabilities of HOS cells were weakened, leading to an anti-tumor effect in a mouse subcutaneous tumor model. In conclusion, our study identified PTT treatment as an approach for preventing osteosarcoma invasion by inhibition of M2 polarization.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-tumor effect; Graphene oxide; M2 polarization; Macrophage; Photothermal therapy (PTT)

Mesh:

Substances:

Year:  2020        PMID: 32473533     DOI: 10.1016/j.jphotobiol.2020.111913

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  7 in total

1.  ICG-Loaded PEG-Modified Black Phosphorus Nanosheets for Fluorescence Imaging-Guided Breast Cancer Therapy.

Authors:  Wanwan Pan; Weijian Chen; Yuanzeng Min; Jing Wang; Zhenye Yang; Tian Xu; Fazhi Yu; Guodong Shen; Yuan Hu; Xiaopeng Ma
Journal:  ACS Omega       Date:  2021-12-15

2.  Enzyme-Loaded Catalytic Macrophage Vesicles with Cascade Amplification of Tumor-Targeting for Oxygenated Photodynamic Therapy.

Authors:  Ling Liu; Jiayu Zhang; Zinan Li; Yang Yang; Longyun Li; Yuyang Zhao; Jia Zhao
Journal:  Int J Nanomedicine       Date:  2021-11-25

Review 3.  Graphene and graphene oxide with anticancer applications: Challenges and future perspectives.

Authors:  Ali Shafiee; Siavash Iravani; Rajender S Varma
Journal:  MedComm (2020)       Date:  2022-02-09

4.  The effects of the oral administration of graphene oxide on the gut microbiota and ultrastructure of the colon of mice.

Authors:  Jiamen Shen; Jiatian Dong; Mingsheng Fu; Yuankun Cai; Jiaying Zhao; Tao Ye; Lifeng Gong; Huipeng Wang; Wenjie Chen
Journal:  Ann Transl Med       Date:  2022-03

Review 5.  Stimulation of Innate and Adaptive Immune Cells with Graphene Oxide and Reduced Graphene Oxide Affect Cancer Progression.

Authors:  Muhammad Amir Yunus; Muhammad Mahyiddin Ramli; Nurul Huda Osman; Rafeezul Mohamed
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-07-29       Impact factor: 4.291

Review 6.  Low-Temperature Photothermal Therapy: Strategies and Applications.

Authors:  Xiulin Yi; Qiu-Yi Duan; Fu-Gen Wu
Journal:  Research (Wash D C)       Date:  2021-05-07

Review 7.  Graphene-Oxide-Enriched Biomaterials: A Focus on Osteo and Chondroinductive Properties and Immunomodulation.

Authors:  Alessia Ricci; Amelia Cataldi; Susi Zara; Marialucia Gallorini
Journal:  Materials (Basel)       Date:  2022-03-17       Impact factor: 3.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.